VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Women aged 25-75 years old                         │ Women aged 25-75 years old                         │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Women with recently diagnosed breast cancer and    │ Women with recently diagnosed breast cancer and    │     100 │
│ who will receive NAC to reduce tumor burden before │ who will receive NAC to reduce tumor burden before │         │
│ surgery. (including locally advanced breast cancer │ surgery. (including locally advanced breast cancer │         │
│ (LABC) according to clinical assessment; or tumor  │ (LABC) according to clinical assessment; or tumor  │         │
│ size \> 2cm, that is, at least T2 in TNM staging)  │ size > 2cm, that is, at least T2 in TNM staging)   │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Women who received metallic fixation, coronary     │ Women who received metallic fixation, coronary     │     100 │
│ artery stent in recent 3 months; or women who      │ artery stent in recent 3 months; or women who      │         │
│ received mechanical valve replacement that is not  │ received mechanical valve replacement that is not  │         │
│ compatible with MR magnet; or women with           │ compatible with MR magnet; or women with           │         │
│ aneurysmal clips, pacemakers                       │ aneurysmal clips, pacemakers                       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Past history of claustrophobia                     │ Past history of claustrophobia                     │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Women who are pregnant or who are planning to be   │ Women who are pregnant or who are planning to be   │     100 │
│ pregnant, or who are lactating (though the         │ pregnant, or who are lactating (though the         │         │
│ possibility in our target population should be     │ possibility in our target population should be     │         │
│ very low)                                          │ very low)                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Past history of breast cancer within recent 5      │ Past history of breast cancer within recent 5      │     100 │
│ years before the currently diagnosed breast cancer │ years before the currently diagnosed breast cancer │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Women who received chemotherapy for other disease  │ Women who received chemotherapy for other disease  │     100 │
│ entity in recent 1 year                            │ entity in recent 1 year                            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Women who cannot cooperate with the examinations   │ Women who cannot cooperate with the examinations   │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Estimated GFR (eGFR) \< 60 mL/min/1.73 m2 and      │ Estimated GFR (eGFR) < 60 mL/min/1.73 m2 and blood │      99 │
│ blood glucose \> 135 mg/dl; Past or present        │ glucose > 135 mg/dl; Past or present history of    │         │
│ history of acute renal failure, renal dialysis,    │ acute renal failure, renal dialysis, diabetes      │         │
│ diabetes mellitus                                  │ mellitus                                           │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                  │   Score │
╞═══════════════════════════════════╪════════════════════════════════╪═════════╡
│ Must be FEMALE                    │ Past history of claustrophobia │      18 │
├───────────────────────────────────┼────────────────────────────────┼─────────┤
│ Must have maximum age of 75 Years │ Women aged 25-75 years old     │      44 │
├───────────────────────────────────┼────────────────────────────────┼─────────┤
│ Must have minimum age of 25 Years │ Women aged 25-75 years old     │      47 │
╘═══════════════════════════════════╧════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 96
Average Levenshtein Ratio of individual lines: 84.0
OverAll Ratio: 90.0
